Mobile

A comparison of the efficacy of Symbicort Single inhaler Therapy (Symbicort Turbuhaler 160/4.5 microg, one inhalation twice a day plus as-needed) and conventional best standard treatment for the treat...

Update Il y a 5 ans
Reference: EUCTR2004-000679-32

A comparison of the efficacy of Symbicort Single inhaler Therapy (Symbicort Turbuhaler 160/4.5 microg, one inhalation twice a day plus as-needed) and conventional best standard treatment for the treatment of persistent asthma in adolescents and adults. A randomised, open, parallel-group, multicentre, 26 weeks study

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to compare the efficacy of Symbicort Single Inhaler Therapy with conventional best standard treatment in patients with persistent asthma.

Inclusion criteria

  • This is a Phase IIIB trial to be conducted in patients with persistent asthma

Links